Applied Therapeutics Inc - ESG Rating & Company Profile powered by AI
This dashboard contains a questions and answers section about Applied Therapeutics Inc. Comprehensive ESG assessment of Applied Therapeutics Inc are accessed by signing in. This report of Applied Therapeutics Inc is prepared by All Street Sevva using leading AI.
Applied Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 4.0, social score of 4.8 and governance score of 4.8.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | Applied Therapeutics Inc | 4.5 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Applied Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Applied Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Applied Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Applied Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Applied Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Applied Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Applied Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Applied Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Applied Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Applied Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Applied Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Applied Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Applied Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Applied Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Applied Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Applied Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Applied Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Applied Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.